News

National Property REIT Corp. Achieves Notable Sale and Returns

National Property REIT Corp. Achieves Notable Sale and Returns

National Property REIT Corp. Celebrates a Successful Property Sale

National Property REIT Corp. ("NPRC"), a key player in property investment, has made headlines with its recent sale of the Crown Point Apartments. This impressive transaction underscores NPRC's commitment to strategic growth and value creation in the multifamily sector.

Highlights from the Crown Point Transaction

The Crown Point Apartments sale was valued at $151.75 million, yielding a robust internal rate of return (IRR) of 19.1% and a 2.6x cash-on-cash multiple for investors. Such strong performance illustrates NPRC's strategic proficiency in navigating the real estate market.

Building a Diverse Property Portfolio

Since its inception, NPRC has developed a substantial portfolio, which includes 110 properties across various sectors. This diverse collection features 83 multifamily residential units, complemented by self-storage facilities, student housing, and senior residential properties. In total, NPRC manages an impressive 36 million rentable square feet, reflecting its robust market presence.

Investment Philosophy and Future Directions

Mack Levine, Vice President of NPRC, emphasized the disciplined investment approach that guided the Crown Point sale. Levine remarked, "This sale highlights our disciplined investment approach and focus on long-term value creation. Crown Point has been a strong performer within our portfolio, and this exit allows Prospect Capital Corporation to redeploy capital into opportunities that further Prospect's strategic objectives." This commitment to long-term value will continue to shape NPRC's investment strategies moving forward.

Professional Support in the Transaction

The successful execution of the Crown Point sale was facilitated by the experienced team at CBRE, including industry veterans Jeffrey Dunne, Eric Apfel, Stuart Mackenzie, and Travis Langer. Their expertise undoubtedly contributed to the timely and efficient handling of this significant transaction.

About National Property REIT Corp.

NPRC is a private REIT dedicated to acquiring real estate properties that emphasize multifamily residential units. The company not only purchases properties outright but also engages in joint ventures with proficient operating partners. Presently, NPRC's multifamily portfolio boasts 44 properties with a market value of approximately $3.2 billion.

Financial Assistance from Prospect Capital Corporation

Being a wholly owned subsidiary of Prospect Capital Corporation (NASDAQ: PSEC) amplifies NPRC's investment capabilities. As of the latest reports, Prospect Capital manages $6.8 billion in total assets, giving NPRC a significant backing to pursue further investments and expand its portfolio strategically.

Contact Information

For further inquiries, individuals can reach out to Scott Ramsey, Managing Director at NPRC. He can be contacted via email at SRamsey@npreitcorp.com or by phone at (646) 536-9906.

Frequently Asked Questions

What was the key outcome of NPRC's recent property sale?

NPRC achieved a 19.1% internal rate of return and a 2.6x cash-on-cash multiple from the sale of Crown Point Apartments.

How diverse is NPRC's property portfolio?

The portfolio includes 110 properties, spanning multifamily residential, self-storage, student housing, and senior living sectors, totaling 36 million rentable square feet.

Who facilitated the Crown Point transaction?

The transaction was represented by a team from CBRE, led by experienced professionals in the industry.

What is NPRC's focus in real estate investment?

NPRC primarily focuses on acquiring multifamily residential properties, supplemented by strategic joint ventures.

How is NPRC supported financially?

NPRC is a wholly owned subsidiary of Prospect Capital Corporation, providing it with substantial resources to pursue new investment opportunities.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Steel Dynamics Gears Up for Q3 2026 Earnings Update

Updated Category News Views 4

Steel Dynamics Preps for Key Earnings Report Folks, we're staring down the barrel of another quarterly earnings report from Steel Dynamics, Inc., and you can bet this one is gonna have plenty of eyes glued. October 19th, 2026, that's when they'll peel back the curtain on how they fared in Q3. Now, buckle up, because this isn't just a numbers game—it’s a snapshot of...

Continue Reading
Lupin Secures FDA Nod for Key Injectable Drug

Updated Category News Views 2

Lupin's FDA Approval: A Strategic Play in Pharmaceuticals Ah, the thrill of a new approval! Lupin Limited has landed U.S. FDA approval for their Phytonadione Injectable Emulsion, marking a significant stride into the lucrative realm of vitamin K treatments. This approval isn't just a feather in Lupin's cap—it's a calculated move to corner a piece of the estimated $52.3...

Continue Reading
Mexico's Beaches Shine in 2026 Best America Rankings

Updated Category News Views 4

Mexican Shores Turning Heads in 2026 This isn’t just another wave in tourism news; it’s a tidal shift towards Mexico’s sizzling beaches claiming some prime spots on the global travel stage. If you’ve got an eye for tourism dynamics, listen up because Mexico’s sun-soaked shores just snagged six spots among the top 20 beaches in the Americas, according to the...

Continue Reading
Aspen Dental Brings Comprehensive Care to Whiteville

Updated Category News Views 4

Bringing Dentistry Closer to Home Now, Whiteville's dental game just got a power-up, with Aspen Dental setting up shop in town. This isn't just another practice popping up—it's a full-on dental hub offering everything from regular cleanings to emergency tooth fixes. And let’s face it, this area's diverse population needs it. The Man Behind the Chair Guess who’s at...

Continue Reading
Striveworks: Boosting Army's AI Edge in Indo-Pacific

Updated Category News Views 4

The world keeps marching forward, and here’s Striveworks stepping up to the plate with another big move in the military tech space. This isn't your average partnership renewal; this involves a five-year, $200 million deal to enhance battlefield AI as the U.S. Army hones its modern warfare edge in the Indo-Pacific. Now, this isn't just a battle of strategies but a battle...

Continue Reading
Protecting Your Family on Halloween: Safety Tips

Updated Category News Views 3

Avoid Turning Halloween Fun Into a Medical Emergency Halloween should be about ghosts and ghouls, not a dreaded detour to the ER. Yet, every year, adults and kids get carried away with costumes, only to find themselves in a real-life horror show courtesy of a slip, a fall, or a carving mishap. The American Academy of Orthopaedic Surgeons (AAOS) is waving the safety flag,...

Continue Reading
Rutter Mills Secures $13M in Virginia Injury Cases

Updated Category News Views 3

The Stakes in Virginia When you drop nine successful injury cases on the scales and they tip over $13 million, that's a story worth dissecting. The two top dogs at Rutter Mills certainly know how to make a splash in the legal puddle, don't they? We're talking about attorneys Adam H. Lotkin and Georgina D. Montgomery here, the legal eagles behind these jaw-dropping...

Continue Reading
Ajman Tourism Department Hits Internal Audit Milestone

Updated Category News Views 2

A Nod to Standards in Ajman's Tourism Department Folks, it's not every day you see a government department get this kind of spotlight in the internal audit arena, yet here we are. The Ajman Department of Tourism, Culture and Media has snagged Full Conformance with Internal Audit Quality Standards. That’s not just some random feather in their cap but a signal flare in...

Continue Reading
Newfold Digital Revamps Leadership for Growth Surge

Updated Category News Views 2

Steering into New Horizons with Fresh Leadership October 2026 marks a fresh chapter for Newfold Digital, as they shuffle the deck chairs a bit and ramp up for some ambitious growth endeavors. This web and commerce tech company decided it's time to bring a few heavy hitters on board. Starting this month, watch out for Sachin Puri taking the reins as Chief Executive...

Continue Reading
CME Group Unveils First Baseball Futures Market

Updated Category News Views 4

A New Pitch in the Financial Ballpark Alright, listen up: CME Group is stepping up to the plate with a game-changer. They’re rolling out the world’s first baseball futures, launching October 12, assuming regulators give the green light. Now, this isn’t just some novelty act; it’s based on the solid groundwork of their FutureSports Performance Indexes (CME FSPI),...

Continue Reading

Top 5 Most Recently Viewed Articles

Medicus Pharma Welcomes Dr. Faisal Mehmud as CMO

Updated Category News Views 203

Medicus Pharma Welcomes a New Chief Medical Officer Medicus Pharma Ltd (NASDAQ: MDCX) is excited to announce a significant addition to its leadership team with the appointment of Dr. Faisal Mehmud as Chief Medical Officer. His extensive background in clinical development and medical affairs will greatly enhance the company’s capabilities in advancing innovative...

Continue Reading
SSATI Expands Services Through Strategic Acquisitions in Tech

Updated Category News Views 167

SSATI Expands Its Capabilities with New Acquisitions Sensible Solutions and Technologies, Inc. (SSATI) has recently made headlines by successfully acquiring Invex Technology Solutions, LLC and ITIC Corporation's government support services. This significant step is aimed at enhancing SSATI's offerings and expanding its footprint within the national security community....

Continue Reading
Olympus Property Expands Portfolio with Luxury Community Acquisition

Updated Category News Views 357

Olympus Property Acquires The Griff in Nashville Olympus Property is excited to announce its recent acquisition of The Griff, a premier 255-unit luxury apartment community strategically positioned in a vibrant submarket. This modern living space, developed in 2019, perfectly embodies urban elegance while offering residents unmatched access to the cultural and economic...

Continue Reading
MrBeast's Wild New Challenge: Live In A Jet for 100 Days

Updated Category News Views 1067

The Daring Challenge by MrBeast Jimmy Donaldson, known for his outlandish challenges and stunts, is back with another exciting giveaway, this time involving a private jet. The popular content creator, fondly referred to as MrBeast, recently made headlines by engaging two newly graduated pilots in a unique contest that promises incredible rewards. Details of the Challenge...

Continue Reading
Ascletis Progresses in Phase I Trial for Innovative Psoriasis Treatment

Updated Category News Views 316

Ascletis Develops Innovative Oral Psoriasis Treatment Ascletis Pharma Inc. has taken a significant step forward in the clinical trial of its groundbreaking oral treatment, ASC50, designed for psoriasis patients. This Phase I trial is essential to assess not only the safety and tolerability but also the preliminary efficacy of this novel drug. The trial's completion of...

Continue Reading